Aspen Aerogels (NYSE:ASPN) Updates Q1 2026 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.280–0.240 for the period, compared to the consensus estimate of -0.220. The company issued revenue guidance of $35.0 million-$40.0 million, compared to the consensus revenue estimate of $44.3 million.

Aspen Aerogels Price Performance

ASPN stock opened at $3.58 on Wednesday. The business’s fifty day moving average price is $3.32 and its 200 day moving average price is $5.10. Aspen Aerogels has a 12-month low of $2.80 and a 12-month high of $9.78. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $295.97 million, a PE ratio of -0.96 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.10). The firm had revenue of $41.34 million during the quarter, compared to analyst estimates of $44.25 million. Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, sell-side analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ASPN. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Zacks Research upgraded shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Barclays cut their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research report on Friday, November 7th. Finally, Canaccord Genuity Group decreased their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $6.67.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently bought and sold shares of ASPN. Invesco Ltd. raised its stake in Aspen Aerogels by 237.9% in the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after buying an additional 2,907,558 shares in the last quarter. XTX Topco Ltd raised its position in shares of Aspen Aerogels by 786.1% during the 4th quarter. XTX Topco Ltd now owns 202,030 shares of the construction company’s stock worth $572,000 after acquiring an additional 179,231 shares in the last quarter. Quadrature Capital Ltd raised its position in shares of Aspen Aerogels by 248.5% during the 4th quarter. Quadrature Capital Ltd now owns 35,583 shares of the construction company’s stock worth $101,000 after acquiring an additional 25,373 shares in the last quarter. Numerai GP LLC lifted its stake in Aspen Aerogels by 1,277.9% during the fourth quarter. Numerai GP LLC now owns 251,888 shares of the construction company’s stock worth $713,000 after purchasing an additional 233,608 shares during the last quarter. Finally, Oxford Asset Management LLP acquired a new position in Aspen Aerogels in the fourth quarter valued at approximately $68,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.